Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix granted inducement equity awards to eight newly hired non-executive employees under its 2019 Inducement Stock Incentive Plan. The grants, effective November 2, 2026, include options on 35,775 shares at a $6.73 exercise price and RSUs covering 11,725 shares, with standard four-year and three-year vesting schedules.
Key figures
- Rsu shares
- 11725
- Option shares
- 35775
- Employees granted
- 8
- Option exercise price
- 6.73
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.